Listenly

How many Medicare J codes for specialty drugs on the medical benefit showed price drops in Q1 2025 to Q1 2026?

Answered at 9:00 in AH118 - Chemo, Cars, & Where Health Plan Savings May be Hiding, with Brian Cotter · The Astonishing Healthcare Podcast

— questions searchable right now

How many Medicare J codes for specialty drugs on the medical benefit showed price drops in Q1 2025 to Q1 2026?

Between Q1 2025 and Q1 2026, 431 drugs had price drops, with some dropping up to 99%. From Q1 2026 to Q3 2026 (first three quarters of the year), 348 drugs had price drops in the medical benefit.

Brian Cotter on The Astonishing Healthcare PodcastAll answers from this podcast →
Full answer and detailsRead the whole answer, key facts and every other question from this episode

In short

Between Q1 2025 and Q1 2026, 431 drugs had price drops, with some dropping up to 99%.

Brian Cotter, Founder at Bright Spot Insights · AH118 - Chemo, Cars, & Where Health Plan Savings May be Hiding, with Brian Cotter · The Astonishing Healthcare Podcast · answer at 9:00

Key takeaways

  • Between Q1 2025 and Q1 2026, 431 drugs had price drops, with some dropping up to 99%.

Quote to remember

“Assume the data is incorrect until proven otherwise. You need to work through the steps to validate the data before you can start digging in and understanding what price variation you see.”

— Brian Cotter

The full answer · about 1 min

Between Q1 2025 and Q1 2026, 431 drugs had price drops, with some dropping up to 99%. From Q1 2026 to Q3 2026 (first three quarters of the year), 348 drugs had price drops in the medical benefit.

Key facts

  • Oxaliplatin ASP price dropped from $2,053 in 2012 to $9.40 in Q1 2026—a 99% reduction
  • One hospital listed oxaliplatin at $29,595 compared to Medicare reimbursement under $10
  • Specialty drug spend now represents 55-60% of pharmacy spend
  • Pharmacy spend represents 25-30% of total plan spend
  • 431 drugs had price drops between Q1 2025 and Q1 2026, with drops up to 99%

People, companies and topics mentioned

Bright Spot InsightsMedicareASP (Average Sales Price)J code (J9263 for oxaliplatin/Eloxatin)Oxaliplatin (Eloxatan)Specialty drugs (oncology)Price transparency dataMedical benefit

More answers from this episode

 ·  All answers from The Astonishing Healthcare Podcast →
—
—
0:00
0:00